Dual listed Oilex joined AIM in 2006, focused on developing a strong position in the highly prospective producing basins in India. Expansion elsewhere since then has failed and nine wells drilled in India over the last 10 years have disappointed. Plus, JV partner problems and a looming licence expiry have made investors cautious. However, in 2016 new management took control and are dealing with the issues.
Established player providing access to a booming Indian energy market
India is one of the fastest growing economies on the planet. The country relies on imports for 80% of its oil needs and LNG (Liquified Natural Gas) imports are expected to double by 2020, despite the country having some highly prospective world-class hydrocarbon basins. Oilex is one of a very small number of foreign companies operating in India today.
Drilling to begin in 2018 using state-of-the-art fracking technology
Schlumberger/Baker Hughes has identified the problems in the old wells and have a blueprint for success. One re-entry and two vertical wells are planned for H2 2018, probably funded by a new JV partner farming in, with Oilex retaining a 30% to 45% stake in the vast well-regarded Cambay block. Given success, a horizontal well could be drilled in December 2018 and crossing over in 2019.
Premium gas price project as production will substitute imported LNG
India relies on imported LNG to fill the energy gap. Oilex is just 15km away from a major high-pressure pipeline taking re-gassed LNG from the port to Delhi and Mumbai, so is well placed to be able to gain a premium price.
Discounted cash flow analysis suggests upside of 680%
Due to legacy problems the stock now has a shell company valuation. By any yardstick, the shares look well-oversold in our view. We initiate coverage of Oilex with a target price of 1.60p and Conviction Buy stance.
Oilex Ltd is a research client of Align Research. Align Research holds an interest in the shares of Oilex Ltd. For full disclaimer information please refer to the last page of the full document. This investment may not be suitable for your personal circumstances. If you are in any doubt as to its suitability you should seek professional advice. This note does not constitute advice and your capital is at risk. This is a marketing communication and cannot be considered independent research.
|Year to Dec||2016A||2017A||2018E||2019E|